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Abstract  
Background 
Safe and timely access to effective and appropriate medication through primary care 
settings is a major concern for all countries addressing both acute and chronic disease 
burdens. Legislation for nurses and other professionals allied to medicine to prescribe 
exists in a minority of countries, with more considering introducing legislation. 
Although there is variation in the range of medicines permitted to be prescribed, 
questions remain as to the contribution prescribing by nurses and professionals allied 
to medicine makes to the care of patients in primary care and what is the evidence on 
which clinicians, commissioners of services and policy makers can consider this 
innovation.  
Methods 
A integrative review of literature on non-medical prescribing in primary care was 
undertaken guided by dimensions of health care quality: effectiveness, acceptability, 
efficiency and access.  
Results 
19 papers of 17 empirical studies were identified which provided evidence of patient 
outcome of non medical prescribing in primary care settings. The majority were 
undertaken in the UK with only one each from the USA, Canada, Botswana and 
Zimbabwe. Only two studies investigated clinical outcomes of non-medical 
prescribing. Seven papers reported on qualitative designs and four of these had fewer 
than ten participants. Most studies reported that non medical prescribing was widely 
accepted and viewed positively by patients and professionals. 
  
Conclusions 
Primary health care is the setting where timely access to safe and appropriate 
medicines is most critical for the well-being of any population. The gradual growth 
over time of legislative authority and in the numbers of non-medical prescribers, 
particularly nurses, in some countries suggests that the acceptability of non-medical 
prescribing is based on the perceived value to the health care system as a whole. Our 
review suggests that there are substantial gaps in the knowledge base to help evidence 
based policy making in this arena. We suggest that future studies of non-medical 
prescribing in primary care focus on the broad range of patient and health service 
outcomes and include economic dimensions.  
 
  
 
Background  
 
Safe and timely access to effective and appropriate medication through primary care 
settings is a major concern for all countries addressing both acute and chronic disease 
burdens [1]. From the nineteenth century onwards, governments have responded to 
concerns for public protection and concerns about drug misuse through medicine 
regulation legislation. By the twentieth century, legislation started to incorporate 
prescriptive authority restricted to a small number of occupational groups such as 
doctors, dentists and vets for certain classes of drugs [2]. Medicine regulation has 
developed at different rates in high and low income countries, as has the mechanisms 
to enforce them. The development in the later part of the twentieth century of a more 
effective range of medicines has seen a different set of public health preoccupations 
which range from the prevention of antibiotic resistance, to issues both of how to fund 
and contain medicine costs in health care systems and at the same time ensure equity 
of access for citizens to basic health care and essential medicines [1]. Each country 
places different emphasis on these issues but in many it has led to consideration of the 
use of other health professional groups in addition to doctors to prescribe regulated 
classes of medicines or medicines provided through a state sponsored or funded health 
care provision.  
 
Non-medical prescribing (NMP) is one term that is used to describe the extension of 
prescriptive authority to professional groups other than the medical profession such as 
nurses, midwives and allied health professions. Data is not easily available on the 
extent of NMP for all 194 member states of the World Health Organisation. We have 
identified, through internet searches, the literature search described below and 
  
personal communications, 22 countries which have legislation giving prescriptive 
authority to nurses (see Table 1 [3, 4]).   
 
Some other countries, for example Spain, the Netherlands, Finland, Jamaica and Hong 
Kong have initiated efforts to introduce legalisation on NMP [4]. There is great 
variety in the prescribing legislation of different countries. Some countries legislate 
for the initial qualification and registration of the nurse as sufficient to undertake 
prescribing certain classes of medicines and in certain situations, for example Kenya, 
while others require further qualifications, for example Namibia. Within a country 
there can also be variations between the extent of classes of medicines nurses can 
prescribe either as a result of different state legislation, for example the United States 
of America (USA) or different levels of prescribing qualifications, for example in the 
United Kingdom (UK). In the UK ‘independent prescribing’ qualifications allows 
almost all medicines to be prescribed within the individual’s clinical competence and 
‘community practitioner prescribing’ qualification gives only authority over a small 
limited nurses formulary. In addition, many countries have mechanisms whereby 
individual nurses (or other professionals) have authority, agreed by their employer 
and /or doctor responsible for a service, to prescribe and dispense or administer a 
specified list of medicines to a pre-defined group of patients in specific circumstances 
and within specified parameters. Common international examples of this are within 
public health immunisation programmes [5]. These are known by a variety of names 
such as standing orders.  In the UK these are known as patient group directions [6] 
and are used widely across the spectrum of health services [7]. 
 
  
In the last fifty years different models of primary care have developed in countries, 
influenced by health care funding, government policies and the aspirations of family 
medicine and general practice [8]. The extent to which groups of professionals such as 
nurses and pharmacists are present in the primary care system of each country is 
dependent on both history and these current policy imperatives. This varies between 
countries even neighbouring in the same continent, for example, the UK has seen 
significant numbers of nurses employed in general practice over the past thirty years 
[9], where as there are small numbers of nurses employed in primary care in France 
[10].   
Extending prescribing authority in primary care is a health care innovation driven by 
various factors in each country. Addressing shortages of medical staff particularly in 
remote and rural areas has been one driving factor in North America, Africa and 
Australia [11, 12]. In African countries such as South Africa, Botswana, Uganda and 
Zimbabwe, the aim has been to meet community health care needs by improving 
access to medicines [13]. In Sweden, the UK and New Zealand; NMP was 
commenced in order to improve the efficiency of services for specific groups, such as 
elderly people or those who receive nursing care in the community [14, 15]. In some 
countries, the aspirations of professional groups have been significant in changes to 
the legislation [16] but only when they have coincided with other public health and 
health policy imperatives. In summary, the key policy goals to date have been to 
improve patient access in primary care settings to safe, timely and effective medicines 
and increasing the efficiency of health service delivery. However, NMP exists in a 
minority of countries and the extent of prescriptive authority is contentious in some 
[17].  A sociological narrative review has explored these dimensions further [18]. 
Other recent narrative reviews [19, 20] have considered nurse prescribing in any 
  
setting without acknowledging that prescribing in primary care is a very different 
context from a hospital setting. In primary care settings the prescriber may have little 
immediate access to other professionals and may be seeing patients with previously 
undiagnosed illnesses. Therefore the question remains as to the contribution NMP 
makes to the care of patients in primary care and what is the evidence on which 
clinicians, commissioners of services and policy makers can consider this innovation.  
 
There is increasing interest in many health care systems to evaluate interventions and 
innovations in terms of the outcomes for patients, rather than just examine structural 
and process elements. Donabedian defines the outcome of care as “the effects of care 
on the health status of patients and populations. Improvements in the patient’s 
knowledge and salutary changes in the patient’s behaviour are included under a broad 
definition of health status, and so is the degree of the patient’s satisfaction with care” 
[21], p. 1745. Donabedian differentiates this from the structural elements i.e. the 
attributes of the setting in which care occurs and the process elements i.e. what is 
actually done in giving and receiving care [21]. This paper reports on an integrative 
review of the empirical literature [22] which addressed the question what is the effect 
of NMP in primary care and community settings on patient outcomes? 
 
Methods 
 
A search strategy was devised to include published and grey literature. The electronic 
data bases CINAHL, MEDLINE, BNI, AMED, ISI Web of Knowledge and Index to 
theses were searched. A search to retrieve grey literature was also conducted of 
relevant websites: Google scholar, the Royal College of Nursing, Royal 
  
Pharmaceutical Society, NHS Modernisation Agency, King’s Fund, National Institute 
of Clinical Excellence, Department of Health, and National Prescribing Centre. 
Searches also included follow up of reference lists and key authors. Searching was 
conducted by SB according to the inclusion and exclusion criteria, using terms of 
NMP.  
 
The search terms employed were nurse prescribing, non-medical prescribing, 
supplementary prescribing, independent prescribing, pharmacist prescribing, allied 
health professional prescribing, prescribing rights and prescribing impact and 
outcomes. A combination of these search terms was used. All items within each terms 
section were combined with OR and then each section was combined with AND for 
different combinations of sections that produced the highest result. The inclusion 
criteria and the exclusion criteria were as follows: 
Inclusion criteria 
• Study contains empirical evidence of NMP from any professional group 
with legislative authority  
• Study contains empirical evidence of outcomes  
• Setting: primary care and community  
• Search period:  January 1970 – December 2010 for the USA and October 1994 
– December 2010 for the UK and other countries. These timeframes reflect the 
years when non-medical prescribing was introduced in these countries.  
Exclusion criteria  
• Studies that did not meet inclusion criteria above  
  
• Commentaries, editorials, opinions, guidelines and service audits   
• Papers that did not report the research design or methods used     
Abstracts were identified, screened by two researchers and accepted or rejected based 
on the inclusion and exclusion criteria. Full papers were obtained where the abstract 
was unclear to enable an accurate decision. Full papers were obtained for all included 
papers and data on sample size, prescribing authority type, findings on outcomes and 
process outcomes (as defined above) and study limitations were extracted. Each study 
was considered against the adapted quality checklists relevant to the study design [23, 
24]. Regular meetings were held between the researchers to discuss and agree 
interpretations and to clarify any inconsistencies in the evidence.  
 
Due to the heterogeneity of study methods, participants and outcomes, an overall 
meta-analysis was not appropriate. Instead data are presented narratively through a 
synthesis framed by the dimensions of judging health care suggested by Maxwell 
[25]. These dimensions are of the effectiveness, acceptability, efficiency, equity 
(fairness) and access to health care. The definitions as described by Maxwell were 
used. Effectiveness addresses questions of “whether the treatment or intervention is 
the best available in the technical sense and the overall result of the treatment” [25], p. 
171.  Acceptability considers questions of patient’s perceptions. Efficiency considers 
questions of “whether the output is maximised for the given input or conversely 
whether the input is minimised to achieve the stated output” [25], p. 171. Finally, 
access considers the questions of whether people receive treatment/service when they 
need it [25].   
 
  
 Results  
 
The initial searches produced 1734 abstracts, of which 961 duplicate articles were 
removed. Titles and abstracts were screened by SB and VMD. After reading titles and 
abstracts 375 of the 773 papers were excluded. The remaining 398 papers were 
classified into three categories:  empirical papers (n=184), opinion papers (n=209) 
and literature reviews (n=5). The opinion papers and reviews were excluded.  
 
One hundred and three of the 184 empirical papers were excluded as they did not 
relate to primary care settings and 17 were excluded as they reported combined 
primary and acute care data and it was not possible to separate the data relating to 
primary care (see table 2 [26-41]). The full text of the remaining 64 papers were read 
(SB, RG, RH and VMD) and categorised as to whether they addressed questions of 
structure, process, or outcomes of NMP in primary care. Those presenting evidence 
only on the structure or process were excluded (n=41). In six of the twenty-three 
remaining papers the research question and/or method were unclear or omitted 
important information to enable the quality of the paper to be assessed and were 
therefore excluded. A total of 19 articles of 17 studies reporting on the outcomes of 
NMP were included in the review (Figure.1). Two studies used the same data for two 
publications. Details of the papers are given in Additional File 1.  Most studies were 
conducted in the UK.  The majority investigated the contribution of nurses as a non-
medical prescriber with a small number investigating the more recent development of 
pharmacists as non-medical prescriber (Table 3). Of the 17 studies, seven used 
qualitative methods only, eight quantitative methods and two employed mixed 
methods designs. We now turn to consider the evidence within the studies as grouped 
  
by questions of effectiveness, efficiency, acceptability and access. Issues of equity are 
considered within the section on access.  
 
Effectiveness 
 
Effectiveness addresses questions of whether the treatment or intervention is the best 
available in the technical sense and the overall result of the treatment [25]. Fifteen of 
the seventeen studies investigated some aspect of the effectiveness of NMP in primary 
care. Of these 15 studies, thirteen investigated nurse prescribing and two pharmacists 
prescribing. Six of  these studies used qualitative semi-structured and in-depth 
interviews [42 - 47], seven  used quantitative questionnaire surveys and secondary 
data analysis [48-54] and two  applied a mixed methods approach [55,56]. The 
majority of studies considered effectiveness of service delivery and only one of the 
studies considered therapeutic effectiveness [53]. 
 
 Four studies from UK, Canada, Botswana and Zimbabwe, which analysed patient 
clinical accounts, reported substantial increases in the prescription by NMP of non-
steroidal anti-inflammatory [49 ], cardiovascular [50 ] and antibiotic medicines [54 
56]. They give an indication of both the conditions that non-medical prescribers were 
encountering and also of the numbers or confidence of non-medical prescribers to 
prescribe these medicines. Only two studies presented comparative data from general 
practitioners indicating similar frequency of prescribing but not by groups of 
medicines [51, 53].  
 
  
Three studies describing patient views [43, 48 and 57] and one of clinical consultation 
review [58] reported that NMP were effective in improving the provision of 
information, advice and understanding on treatment, conditions, self-care and 
standard of care. One study describing data from the professional viewpoints reported 
that NMP had enhanced concordance with patients [46]. One study which analysed 
clinical records [53] reported that the NMP intervention improved patient reported 
outcomes of treatment. None of these studies present any other data as evidence to 
support these viewpoints.  
 
Most of the studies were not able to comment on the effectiveness of NMP in primary 
care in relation to safety and appropriateness of prescribing by nurses and other 
professionals allied to medicine. However, there is some evidence from two studies in 
two different African countries that some prescribing of antibiotics by those nurses 
may have been inappropriate and not evidence-based [54, 56].  Neither presents 
comparative data to judge whether other professionals such as doctors in that type of 
setting prescribed in similar or different ways. A mixed methods survey of adherence 
to treatment guidelines in primary health care facilities in Botswana found that 
antibiotics were prescribed in 27% of all 2994 consultations. The study reported that 
full adherence to prescribing guidelines (defined as complete adherence to national 
recommended treatment guidelines) occurred in 44% of prescriptions, acceptable 
compliance in 20%, acceptable but with one or more useless although not dangerous 
drugs in 33% and insufficient or dangerous treatment in 3% of the consultations [56]. 
An unspecified survey of antibiotic prescribing by nurses in primary care clinics in 
Harare, Zimbabwe found that of 1000 patient (presumably records but not specified in 
the paper) surveyed 543 were prescribed with antibiotics. It was reported that 12.3% 
  
of patients were prescribed antibiotics inappropriately [54]. The same study 
referenced an unpublished paper reporting on a previous small survey which was 
carried out in a paediatric primary care clinic in Zimbabwe. The study reported that 
55% of children were treated with antibiotics when seen by the nurses but only 22% 
when seen by a paediatrician [59]. 
 
Efficiency 
 
Efficiency considers questions of whether the output is maximised for the given input 
or conversely whether the input is minimised to achieve the stated output [25]. Of the 
17 studies nine considered questions of efficiency; seven of them as a part of a 
broader study and two considered only questions of efficiency using  qualitative [42, 
45] and quantitative [58] methods. All these studies reported prescribing by nurses.  
 
Four studies, one of patient [42] and three of professional views [ 44, 47 and 55], 
reported that NMP was efficient in that it was viewed as easy, convenient and timely 
without the need to wait for a GP appointment. Two studies of nurses’ views reported 
that being able to prescribe enabled them to provide seamless and patient centred care 
[45,46 ].  A UK based observational survey of clinical accounts reported that nurse 
prescribers fully completed the episode of care , i.e. did not have to refer on to a 
doctor, in 65% of patients presenting in the same day appointments using a 
combination of advice and prescriptions [58].  In an American evaluation of 
Advanced Nursing Practitioners (ANP) with prescriptive authority 1,708 patients 
were seen and prescribed by 32 ANPs. An analysis of patient records found that 
patients experienced short waiting times (63% waited 15 minutes or less) [53]. A 
  
Canadian study which analysed two years of prescription claims by older adults 
reported that the number of prescriptions per nurse prescriber doubled and cost per 
prescription increased approximately 20% over the time period [49]. The authors 
noted the increase in cost per prescription; however, they did not interpret this in 
terms of efficiency.  While three studies describing the professional views [44, 49 and 
55] reported that NMP was time saving for patient and nurses only one study, which 
was conducted in the UK, reported NMP as a cost-effective intervention [47].  
 
Acceptability 
 
Acceptability considers questions of suitability and satisfaction from the perspective 
of both those receiving the intervention (the patients) and others providing or 
commissioning the service (the professionals and managers) [25]. It therefore relates 
to perceptions of outcomes. Of the 17 studies in the review, three reported views 
about acceptability as a part of a broader study. Of these three studies, two 
investigated nurse prescribing and one pharmacist prescribing. The studies found that 
NMP was widely accepted and viewed positively by patients [42, 43, 48 and 60].  A 
UK based qualitative study that interviewed 50 patients from caseloads of health 
visitors (n=17), district nurses (n=9) and a practice nurse (n=1) reported that 49 (98%) 
out of 50 study participants were in favour of nurse prescribing and happy with the 
consultation and information  provided by the nurse prescribers [42].  Similarly, 
another UK based study interviewed a sample of 148 patients selected from the 
caseloads of district nurses, health visitors and practice nurses after the treatment 
episode involving non-medical prescriber. The majority of patients interviewed post 
  
prescribing implementation, were in favour of nurse prescribing and 55% of patients 
interviewed had sought advice from a nurse prescriber in preference to the GP [43].  
 
Access 
 
Access considers the questions of whether people receive a treatment or service when 
they need it and whether there are any identifiable barriers to service uptake [25]. Five 
studies considered the question of access as a part of a broader study. Four studies 
considered nurse prescribing and one pharmacist prescribing from UK. Four patient 
views studies [42, 43, 48 and 61] and one clinical consultation review analysis [58] 
reported that introduction of NMP has improved access to medicines and health care 
professionals. A UK based qualitative study, which interviewed 41 patients from 
caseloads of seven nurse prescribers, reported that they thought that their access to 
medicine had improved during non-routine/non-emergency appointments [61]. 
Similarly, another UK study interviewed 305 patients selected from the caseloads of 
nurse prescribers reported that patients appreciated the nurses being accessible 
resulting in no delay in starting medication [43].  A questionnaire study investigating  
the patients’ experience (n= 127) of pharmacist-led supplementary prescribers in a 
UK primary care setting reported that 86% of respondents stated that they are able to 
make appointments easily, which resulted in improved access to medicines [48].  
 
Discussion  
 
  
While there have been previous published reviews of non-medical prescribing, none 
have considered the evidence from one setting, in this case primary care, or have 
focused on outcomes.   
 
In this review, 19 papers of 17 empirical studies (two studies published two articles 
each) were identified which provided evidence of patient outcome of NMP in primary 
care settings. The majority were undertaken in the UK with only one each from the 
USA, Canada, Botswana and Zimbabwe. Seven papers report on UK studies of nurse 
prescribing from a limited nurses’ formulary. Seven papers reported on qualitative 
designs and four of these had fewer than ten participants. Two reported on surveys of 
opinion and experience. Eight papers reported on record reviews of prescriptions or 
clinical consultation by NMPs. Those studies that provide objective measures are 
mainly descriptive. Only one provided some comparative evidence of another type of 
prescriber, GPs, by which to judge the impact on patient outcomes or outcomes on the 
efficiency for the health system [52]. While there may be a publication bias in 
reporting positive outcomes present in those identified, many of the studies included 
in the review had design weaknesses and limitations, both as indicated by the authors 
and evident through critical appraisal of the papers. The strength of evidence they 
provide on the whole is limited.  
 
The review findings from stakeholders’ perspectives suggest that NMP in primary 
care effectively improves patients’ understanding of treatment, condition and self-care 
and provides a better level of care. As the literature suggests that concordance is a 
major issue in the effective use of medicines in primary care settings [62] the impact 
of additional information and advice may be significant in considering which type of 
  
prescriber is effective for which particular patient groups. This proposition requires 
further testing and investigation.  
 
We found very limited evidence in relation to other indicators of effectiveness of 
NMP outcomes such as of patient safety and clinical outcomes. The overall number of 
research-based studies to evaluate impact and outcome of NMP was low given that 
NMP was introduced in many countries over 30 years ago. In part this reflected the 
number of papers excluded as it was not possible to separate primary care related data 
from secondary care related data but it may also be that NMP is seen as producing 
positive outcomes in situations where there are no alternative prescribers. This may 
explain the absence of empirical outcome evidence from low income countries in 
particular, although this may also reflect the review search strategy, which did not 
search country specific journals not indexed on the major electronic databases. Given 
that it is a minority of countries that have given prescribing authority to professionals 
other than doctors and dentists, it may be that it is this type of evidence that would be 
of value to policy makers and requires further investigation and publication.  
 
In relation to efficiency of NMP in primary care, the review suggests that patients 
received services that were timely, seamless and of high quality from nurse and 
pharmacist prescribers. One study reported opinions that NMP was cost effective in 
primary care. We were unable to find any papers from a health economics perspective 
or that modelled the efficiency impact from either patient or the health services 
perspective. We suggest that this is an aspect that warrants further investigation.  
 
  
All the studies investigating acceptability of NMP indicated that NMP was well 
accepted and favoured by patients, nurses, pharmacists and other health care 
professionals. The gradual growth over time of legislative authority to NMP and also 
of the numbers of non-medical prescribers, particularly nurses, in countries such as 
the USA and the UK, suggests that the acceptability is based not just on immediate 
levels of satisfaction with the clinical encounter but perceived value to the health care 
system as a whole.  
 
The review findings also report that patients considered it was easier, quicker and 
convenient to get an appointment with NMP and their access to medicine and health 
care professionals was improved.  For all countries the issue of timely access to 
appropriate medicines has health service and public health ramifications. For 
countries with well developed primary care services such as the UK, the ability of 
primary care professionals other than doctors to provide consultations that include 
prescribing may improve waiting times to consult and help manage demand and 
potential dissatisfaction. The issue of equitable access to safe and affordable medicine 
is critical for lower-income countries where the access to medicines is compromised 
by insufficient health facilities and staff, low investment in health and the high cost of 
medicines [63]. In these settings if legislative authority to prescribe is not extended to 
groups other than doctors and dentists, using mechanisms such as patient group 
directions or standing orders for community health workers for a specified essential 
drug list and immunisation list may have significant and critical public health impact. 
The contribution of these types of mechanisms with a broader group of community 
health staff is not within the scope of this review but warrants further investigation . 
 
  
This review has limitations in that it included only English language studies and those 
accessed through electronic sources and therefore may have excluded evidence from 
many Scandinavian, African, South East Asian and South American countries. 
However, our review of countries that have legislated for prescribing authority for 
professionals other than doctors and dentists would suggest that researchers from 
many of these countries are likely to publish evidence in English language journals, 
although not necessarily ones that are indexed through the databases we searched.  
 
Our focus on patient and health service outcomes has been both a strength and a 
weakness: while outcomes are important, the small number of studies finally included 
demonstrate how limited the evidence is. We argue that it is these aspects that most 
urgently need investigation. Our focus on solely primary care has also meant that we 
have had to exclude some more recent studies providing evidence from mixed 
primary and secondary care settings, aspects such as clinical appropriateness of NMP,  
e.g. Drennan et al, 2009 , Latter et al, 2010, and Bissell et al, 2008 [3, 26, 35]. In 
many of these studies there were substantial numbers of NMP in primary care 
settings. We suggest that secondary data analysis of some of these studies by health 
care setting may be invaluable to providing evidence for service planners, 
commissioners and managers.  
Conclusions  
 
NMP has been implemented and evolved differently in different countries. Around 
twenty countries out of 193 member states of the World Health Organisation (WHO) 
provide legal authority to nurses and other professionals allied to medicine to 
prescribe medicines at a certain level and others are considering introducing 
  
legislation. This suggests that internationally twenty first century policy makers are 
beginning to look as to how to move beyond twentieth century established 
professional boundaries for the benefit of both public health and their health care 
economy. Primary health care is the setting where timely, and equitable, access to safe 
and appropriate medicines is most critical for the well-being of any population. Our 
review suggests that there are substantial gaps in the knowledge base to help evidence 
based policy making in this arena. We suggest that this review indicates there is a 
need for secondary data analysis of existing studies and commissioning of new studies 
that address questions of non-medical prescribing in primary care across a broad 
range of patient and health service outcomes, including economic dimensions. 
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Table 1 – Countries with identified legislation for Prescribing by Nurses 
Country Legal Framework for Non-medical prescribing (NMP) 
Australia The Drugs Poisons and Controlled Substances Act 1981 and Nurses 
Act 1993 (Vic) amended with Nurse Amendment Act 2000*. 
Botswana The Drugs and Related Substances Act 1992 grants legal authority 
to RGN to prescribe specific drugs from Botswana National Drug 
Formulary***. 
Canada The College of Registered Nurses of Nova Scotia Regulations 
(Section 27, 2002), approved by government, enabled NPs to 
prescribe from a restricted list of medications known as the 
Authorized Practices Schedule*. 
Kenya Public Health Act Cap 242 of the laws of Kenya allows nurses to 
diagnose and treat minor illnesses in settings without doctors *. 
New Zealand A 2001 regulation under the Medicines Act 1981 enables nurse 
practitioners to become designated prescribers within their defined 
area of practice (e.g., primary health)*. 
Namibia Under Nursing Act (8) 2004 in Namibia Nurse Prescribers are 
allowed to prescribe up to Schedule 4 medicines once they have 
concluded a primary care training course from the Department of 
Health***. 
Republic of 
Ireland 
Introduced in 2007. The Irish Medicines Board (Miscellaneous 
Provisions) Act 2006 (No. 3 of 2006) and its associated regulations 
and the Nurses Rules 2007 [3]. 
South Africa The Section 38A of the Nursing Act, 1978 give rights to nurses to 
prescribe certain classes of medicine. The 38A section of Nursing 
Act no longer exists and Act 101 of the Medicines and Related 
Control Act 1965 amended in 1997 allows to nurses to become an 
authorised prescriber*. 
Sweden Introduced in 1994. District Nurses may prescribe from a National 
Board of Health and Welfare *. 
Uganda National Drug Policy and Authority Statute 1993 was amended in 
2004, which allows nurses to prescribe***. 
United 
Kingdom (UK) 
The Medicinal Products: Prescription by Nurses etc Act 1992, The 
Health and Social Care Act 2001**. 
United States 
of America 
(USA) 
Nurse Prescribing (NP) introduced in 1969. Fifty States allow some 
form of NMP. However, there is no uniformity in law, language and 
regulations among States*. 
In addition we are aware that NPM legislation exists in Cameroon, Zimbabwe, 
Rwanda, Swaziland, Malawi, Tanzania, Zambia, Ghana, Lesotho and Ethiopia****, 
but were unable to identify the specific legislative documents. 
*International Council of Nursing 2009 [4] ** Department of Health *** Personal 
communication **** Internet search  
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Table 3 –Distribution of papers by country and type of NMP    
Country No. Of papers Nurses Pharmacists 
UK 11 X  
 02  X 
USA 01 X  
Canada  01 X  
Botswana  01 X  
Zimbabwe  01 X  
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